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INTRODUCTION
Celiac disease is a chronic, immune illness consisting of permanent intolerance to gluten, which is present in cereals like wheat, barley, rye (1) and, very probably, in certain types of oats (2) , causing inflammation and injury to the small intestine. The disease is considered to be systemic and, if untreated, can give rise to a whole range of gastrointestinal and nutritional problems: osteoporosis, infertility, or some types of lymphoma (10) . The only known treatment to date is a strict life-long glutenfree diet.
In a systematic review, Hall et al. (11) estimate that adherence to the diet is only between 42% and 91% among patients, depending on the definition of adherence and the type of evaluation. As for the impact of non-adherence, Leffler et al. report that 30% of cases with no improvement appear to be related to a continuous exposure to gluten in the diet (12) .
Most tools used to evaluate adherence have been drawn up in languages other than Spanish. Logically, a correct transcultural adaptation allows comparisons of findings between studies (13) . Although on occasions (13, 14) a self-administered adaption of the questionnaire prepared by Morisky et al. (15) has been used for the pharmacological treatment, this team has found no validated tool to measure adherence in Spanish, and each evaluation has always been carried out using selfinformed questions or serological tests.
Other more specific questionnaires include the Biagi Gluten Free Score (16), whose four items offer a score from 0 to IV in which levels 0 and I indicate a low adherence to the diet, level II shows some adherence but with important lapses, while subjects scoring III or IV follow a strict gluten-free diet, although the authors do not distinguish between these two higher levels. This scale has the advantage that it can be applied over the telephone. Another questionnaire is the TPB Questionnaire (17), with 93 items that are answered on a 7-point Likert scale. It fits into the Theory of Planned Behavior (18) and evaluates the strength of patients' beliefs, their evaluation of the consequences (attitude), their motivations for adhering (rules) and the power of their beliefs. While all these questionnaires which seek to evaluate adherence to a glutenfree diet are of interest, the Celiac Dietary Adherence Test (CDAT) offers the greatest possibilities for adaptation, it makes the broadest evaluation and it has begun to be used in research (17) .
In 2009, Leffler developed the CDAT, a short questionnaire that provides a fast, standardized evaluation with a higher level of specificity and sensitivity than can be gleaned from an analysis of levels of tissue antitransglutaminase or self-informed questions (19) .
The CDAT questionnaire comprises 7 questions, it is easy to administer and has optimal psychometric characteristics. The 7 items measure the symptomatology of celiac disease patients, their expectations of self-efficiency and their reasons for following a gluten-free diet, as well as their perceived adherence.
In its original validation, each of the 7 items showed a high correlation with the SDE (Standardized Dietitian Evaluation), a sensitivity of 73.7%, a specificity of 76.7% and 
METHODS

Phase 1: Translation and back translation of the questionnaire
After seeking the author's authorization for the translation of the questionnaire into Spanish, we then contacted bilingual translators. Three translators proffered translations from English into Spanish, the versions were then compared and a consensus was reached. A fourth, independent, translator was employed for the back translation and a satisfactory match was obtained.
Phase 2: Validation of the questionnaire
In order to validate the psychometric characteristics of the Spanish version, a descriptive transversal study was designed using a survey which contained a battery of questionnaires that could be answered online or on paper.
A pilot study was carried out previously on 10 celiac disease patients who responded to the CDAT questionnaire and to the other questionnaires used for the validation process, which were statistically analyzed.
Calculating the sample
The sample size for the analysis was calculated with the recommended 10-15 patients per item (20, 21) , so 70-105 participants were required in total.
Considering the population data, the prevalence of 1% and an infradiagnosis of 1:7 in Aragon, Spain, there are approximately 1,800 known diagnosed celiac disease cases.
Subjects were invited to participate via the main association of patients in the area, and 1,481 invitations (82.28%) were sent to associated celiac patients in Aragon of 12 years of age or more, so participants are deemed to have sufficient language competence to be able to respond to the questionnaire. The study was also publicized through the Public Health System with the aim of recruiting non associated patients.
Participants or in the case of minors their guardians gave informed consent to participate in the research.
Participants could choose to complete the questionnaire online or with a pen and paper version and could send their answers anonymously to the association, which forwarded them to the research team. The survey was carried out between March and June 2015.
Three hundred and six (83.3% women) completed questionnaires were received from the Autonomous Community of Aragon, with respondents' ages ranging from 12 to 72 years, 89.5% of whom were associated at the time (Table I ). The mean number of years' experience of coping with the disease was 5 (range 3-11).
Evaluation of criteria and discriminant validity
Owing to the inexistence of equivalent tests, criteria validity was analyzed using a battery of questionnaires: CeliacSE (22) , GSES (23), Casellas's adaptation (13) of the CD-QOL (24) and SF12.v2 (25) , and these were applied together with the translation of the CDAT made for this study in order to analyze the convergent validity in the dimensions found of symptomatology, self-efficacy and motivations in the gluten-free diet, and self-esteem. The discriminant validity was measured with Spearman correlations for each of these questions with each questionnaire or the dimensions therein.
Adherence to the diet
Adherence to the diet was measured through the CDAT translation with additive scores from 7 to 35, with scores below 13 indicating excellent or good compliance and scores above 17 indicating a limit or poor adherence.
Adherence was also measured through the self-informed question "Do you feel that you are correctly following a gluten-free diet?". The response options were never, hardly ever, sometimes, almost always and always, with "always" corresponding to strict adherence.
Life quality
Overall life quality was measured using the SF-12 v2 questionnaire and the Spanish version of the specific celiac disease questionnaire CD-QOL. The SF-12 questionnaire is a shortened version of the SF-36, which also incorporates a physical component (PCS) and a mental one (MCS) for quality of life. The CD-QOL comprises 20 questions that rate the state of health on a scale from 0 (worst) to 100 (best) and includes four dimensions (dysphoria, limitations, health problems and inappropriate treatment).
Self-efficacy
General self-efficacy was measured using the GSES scale while specific self-efficacy for adherence was measured with the CeliacSE questionnaire. The originally German GSES scale has been translated into 32 languages and has been widely used in a variety of environments. It comprises 10 items that are measured on a 4-point Likert scale ranging from "not at all true" to "exactly true", and uses additive total scores. The CeliacSE scale developed in the framework of this research comprises 20 questions and is divided into 5 areas (shopping, eating out, eating at home with others, travel and work/school). It uses an 11-point scale in which participants score their confidence to carry out a certain behavior in coping with their gluten-free diet. Scores are again additive.
Demographic variables relating to age, sex, marital status, work situation, level of education, membership of a patients association, associated illnesses and prescribed gluten-free diet and the reasons for this were incorporated to describe the sample and find the relevant differences between groups.
Internal validation was evaluated via a feasibility study including ceiling and floor effects and calculation of Cronbach's alpha. The factorial structure was analyzed by studying the main components and varimax rotation with Kaiser normalization. No study has been made to date on stability and resistance to change.
Statistical analysis
The normal distribution fit was studied using the Kolmogorov-Smirnov test. As this was negative, the percentiles 25-75 and non-parametric tests like the Spearman coefficient and the Mann-Whitney U test were used to describe the median and the analysis of differences between samples. The level of significance was p < 0.05. A factorial analysis was made using main components analysis and varimax with Kaiser normalization. 
RESULTS
Stage 1: Translation of the questionnaire into Spanish
After translation and back translation the final questionnaire was as appears in table II, and the original 1-5 scores proposed by the author were maintained. A comprehensibility trial was made with 10 diagnosed and treated patients with no new modifications being incorporated into the questionnaire (Table I) .
Stage 2: Validation of the questionnaire
According to the CDAT and the criteria established by Leffler, 72 .3% of the sample showed an excellent or good adherence to the gluten-free diet and 2.7% a moderate or bad adherence (versus 94.3% who declared in the self-informed question that they always or almost always complied and 59.8% who stated they always complied).
On analyzing the relevance of a factorial analysis we found a KMO of 0.648 and a significant Bartlett sphericity test, with p < 0.01.
The factorial structure shows three factors that account for 65.05% of the variance (Table III) . The first factor, symptomatology, grouped questions 1 and 2; the second one, motivation and self-efficacy, questions 3, 4, 6 and 7, and the third one, question 5, mood.
The feasibility study shows that 100% of the interviewees answered all the questions.
Floor effect was 4.4% and ceiling effect was 1%. An analysis of the internal consistency of each factor to the adaptation returned a moderate Cronbach alpha coefficient of 0.642 and 0.601. The third factor implied only one question.
As regards concurrent validity, the lack of equivalent tests led us to study the Although there are no similar questionnaires to study concurrent validity, this one is suitable as the questions show significant correlations with the dimensions related to general or specific self-efficacy, quality of life and "limitations", "health problems", "inappropriate treatment" and "dysphoria" on the CD-QOL. The tool suitably distinguishes other constructs with which there are no significant correlations.
The internal consistency shows excellent feasibility with all interviewees responding to all the questions and with good floor and ceiling effects below the widely accepted 15% threshold (30) . The moderate levels of the Cronbach alpha, for which we have comparable data in the original, may be due to the low total number of items, to its factorial structure or to the homogeneity of the sample, but they are sufficient for these initial stages of the research (21) .
Most studies on the adherence to a gluten-free diet suffer from a lack of theoretical framework and an exact definition of what strict adherence is (11) . We consider that Social Cognitive Theory (31, 32) can provide this framework and that any tool for measuring adherence to a gluten-free diet should incorporate (as the CDAT does) the expectation of self-efficacy and the motivations for adherence, the associated symptomatology, knowledge of the disease, associated risk behaviors and the subjective perception of adherence. Any of these factors is insufficient in isolation but their combination affords a coherent proposal and it is this that possibly accounts for the good validity of the construct of this test.
The study has some limitations, of which the main one is that it uses self-informed data from questionnaires, with no medical data other than that declared therein, so there are no physiological correlates. These are present in the initial version of the tool developed by Leffler and make that tool solid.
There is also a clear bias towards associated patients with many years' experience of coping with the disease and good adherence to a gluten-free diet, which limits the analyses referring to the low adherence group.
It would, moreover, be useful to apply the questionnaire to other more heterogeneous samples in order to study its internal consistency in greater detail. No test-retest analysis was performed of the Spanish version nor of how change-sensitive it is; these issues should be addressed in future studies.
The tool has some important advantages, including the good properties of the original questionnaire in English, the results of this validation process and its transcultural adaptation, its easy application and the fact that there are currently few similar tools available in the world, and none in Spanish, so we can state that we have a useful tool for clinicians and researchers of celiac disease which offers an alternative to other more expensive or invasive ones. 
